AG
ORIC icon

Algert Global’s Oric Pharmaceuticals ORIC Stock Holding History

Algert Global’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2M Buy
1,215,293
+1,078,943
+791% +$9.78M 0.16% 192
2026
Q1 		$1.73M Buy
136,350
+95,840
+237% +$1.09M 0.03% 744
2025
Q4 		$331K Buy
+40,510
New +$466K 0.01% 991
2023
Q4 		– Sell
-13,430
Closed -$81.3K – 1227
2023
Q3 		$81.3K Buy
+13,430
New +$110K ﹤0.01% 1044

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Algert Global's ORIC Position: Q2 2026 in Review

Algert Global increased its Oric Pharmaceuticals (ORIC) stake by 791% in Q2 2026, buying an estimated $9.78M and bringing the position to 1,215,293 shares worth $13.2M. The position accounts for 0.16% of the portfolio, ranked #192.

Algert Global first reported a position in ORIC in Q3 2023 and has held it in 4 quarters since. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Algert Global held 1,215,293 shares of Oric Pharmaceuticals worth $13.2M as of Q2 2026.
  • Algert Global bought 1,078,943 Oric Pharmaceuticals shares in Q2 2026, an estimated $9.78M.
  • Oric Pharmaceuticals made up 0.16% of Algert Global's portfolio in Q2 2026, its #192 holding.
  • Algert Global first reported a position in Oric Pharmaceuticals in Q3 2023 and has held it in 4 quarters since.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.